This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Preventive care urged as statins cut death risk
A NEJM study on pravastatin in 6,595 healthy men aged 45 to 64 shows five years of treatment lower overall death rates by 22 percent and nonfatal heart attacks by 31 percent, prompting doctors to treat high cholesterol more aggressively while emphasizing lifestyle changes first. The Scottish trial, funded by Bristol-Myers Squibb, involved 200 researchers and cost $30 million.
MENTIONED IN THIS ARTICLE
Anaheim
Calif
New England Journal of Medicine
Sidney Smith Jr
American Heart Association
Smith
West of Scotland
James Fleisher
Tarzana Medical Center
Los Angeles
Terje R. Pedersen
Aker Hospital
Oslo
Norway
Pedersen
James Shepherd
Royal Infirmary
Glasgow
United States
Bristol-Myers Squibb
Dr. Shepherd
Shepherd